Lataa...
Ranibizumab non-response in pachychoroid neovasculopathy: Effects of switching to aflibercept
Non-response to intravitreal ranibizumab represents a frequent problem in pachychoroid neovasculopathy (PNV). To investigate the effectivity of switching to aflibercept, the database of the Ludwig Maximilians University, Munich, was screened for patients fulfilling the following inclusion criteria:...
Tallennettuna:
| Julkaisussa: | Sci Rep |
|---|---|
| Päätekijät: | , , , , , , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Nature Publishing Group UK
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7242401/ https://ncbi.nlm.nih.gov/pubmed/32439930 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-65370-w |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|